ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

15,215Medicare Part D Prescriptions Filled, Including Refills

Rank: 132 out of 682

$700K Total Retail Price of All Prescriptions

Rank: 196 out of 682

377 Patients Receiving at Least One Drug in Part D
55%Patients 65 Years and Older
89% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Kentucky
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 377 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

22% of this provider’s 377 patients filled at least one prescription for a schedule three drug, compared to an average of 17%.

Risky Drugs to Seniors

3% of this provider’s 9,675 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$46 was the average price of a prescription from this provider, compared to $59 among peers.

Prescriptions per Patient

40 is the average number of prescriptions (including refills) per patient, compared to an average of 24.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Kentucky
HYDROCODONE-ACETAMINOPHEN 660 353 S3 1 1
SIMVASTATIN 591 366 2 4
METOPROLOL TARTRATE 452 298 3 10
OMEPRAZOLE 430 232 4 5
METFORMIN HCL 408 274 5 8
LEVOTHYROXINE SODIUM 406 273 6 3
GABAPENTIN 372 169 7 9
FUROSEMIDE 343 267 8 7
LISINOPRIL 283 133 9 2
PRAVASTATIN SODIUM 258 120 10 15
CITALOPRAM HBR 246 144 11 17
AMLODIPINE BESYLATE 230 160 12 6
RANITIDINE HCL 216 101 13 28
DONEPEZIL HCL 213 205 14 30
SERTRALINE HCL 206 114 15 24
LOSARTAN POTASSIUM 204 135 16 20
GLYBURIDE 194 129 R 17 72
ATENOLOL 189 110 18 18
CYCLOBENZAPRINE HCL 156 79 R 19 65
PAROXETINE HCL 152 98 20 53
WARFARIN SODIUM 143 123 21 13
COMBIVENT 142 110 22 105
FAMOTIDINE 141 99 23 99
DICLOFENAC SODIUM 135 70 24 107
ENDOCET 134 49 S2 25 88
LOSARTAN-HYDROCHLOROTHIAZIDE 130 78 26 56
SINGULAIR 126 100 27 63
FLUTICASONE PROPIONATE 124 73 28 36
QUETIAPINE FUMARATE 112 56 29 87
CLOPIDOGREL 111 55 30 25
HYDROCHLOROTHIAZIDE 110 66 31 12
GLIMEPIRIDE 103 89 32 43
POTASSIUM CHLORIDE 101 52 33 14
NYSTATIN 98 83 34 95
SPIRIVA 98 90 34 49
LANTUS 97 86 36 55
LISINOPRIL-HYDROCHLOROTHIAZIDE 95 32 37 34
ISOSORBIDE MONONITRATE ER 93 45 38 31
ADVAIR DISKUS 92 56 39 47
NEXIUM 91 73 40 19
ALLOPURINOL 91 28 40 32
PREDNISONE 88 77 42 40
ROPINIROLE HCL 86 57 43 71
PLAVIX 86 47 43 35
RISPERIDONE 85 83 45 82
MIRTAZAPINE 82 80 46 52
IPRATROPIUM BROMIDE 81 81 47 212
ALBUTEROL SULFATE 80 78 48 156
PROMETHAZINE HCL 79 41 R 49 54
METOPROLOL SUCCINATE 77 57 50 16
MONTELUKAST SODIUM 77 63 50 112
ATORVASTATIN CALCIUM 74 50 52 11
CLONIDINE HCL 74 51 52 48
NAMENDA 72 72 54 41
ALENDRONATE SODIUM 72 70 54 37
JANUVIA 71 51 56 62
CARBIDOPA-LEVODOPA 70 70 57 121
ZOLPIDEM TARTRATE 70 47 57 21
TAMSULOSIN HCL 69 43 59 33
DIVALPROEX SODIUM ER 68 31 60 221
DIGOXIN 66 47 61 46
POLYETHYLENE GLYCOL 3350 65 41 62 44
LEVOFLOXACIN 64 51 63 70
THEOPHYLLINE ANHYDROUS 64 50 63 153
MUPIROCIN 63 48 65 166
CARVEDILOL 63 25 65 23
TRAMADOL HCL 62 40 67 26
EXELON 61 61 68 104
PANTOPRAZOLE SODIUM 61 43 68 29
SEROQUEL 61 33 68 193
LOVASTATIN 61 44 68 66
SPIRONOLACTONE 58 28 72 64
BUSPIRONE HCL 58 48 72 102
CIPROFLOXACIN HCL 58 39 72 58
PROAIR HFA 58 42 72 45
ENALAPRIL MALEATE 57 34 76 91
FENTANYL 57 46 S2 76 86
VENTOLIN HFA 56 27 78 101
IBUPROFEN 53 31 79 79
HALOPERIDOL 53 18 79 238
AZITHROMYCIN 52 26 81 39
FLUOXETINE HCL 51 0 82 60
LACTULOSE 51 18 82 100
CETIRIZINE HCL 50 40 84 289
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 15, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.